Chief Executive Officer
Sally O'Callaghan brings a wealth of experience in managing clinical teams across various healthcare settings, including in Australian public, private and community healthcare sectors and global pharmaceutical organisations, where she has been instrumental in coordinating clinical care and leading teams of clinicians and researchers.
With extensive experience across all facets of critical care, Sally has also coauthored research publications and is an active member of ACTA, a representative on A-CTEC's Advisory Education Committee and has supported several CT:IQ projects, with a keen interest in progressing local research interests and a steadfast commitment to early-phase clinical research.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.